Health
Compass Pathways CEO Warns of Caution
Compass Pathways, a company developing psychedelic therapies for mental health treatment, announced it will proceed cautiously despite upcoming regulatory review.
Coverage timeline — 1 article
STAT News
The CEO of Compass Pathways said the company, whose psychedelic therapy is set for regulatory review this year, is prepared to “go slow before we go fast.”
2026-10-15 00:01 UTC